Procept Biorobotics (PRCT) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Procept Biorobotics Corporation  (NASDAQ: PRCT)
 

Procept Biorobotics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Procept Biorobotics's inventory turnover ratio sequentially decreased to 1.63 in the first quarter 2026, unsurprisingly, as the Procept Biorobotics markets continue to deteriorate, and PRCT's faces growing challenges to bring down its inventories. Procept Biorobotics's average inventory processing period in the Mar 31 2026 quarter, has increased to 224 days, from 220 days, in the Dec 31 2025 quarter.

Within Healthcare sector 244 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 615, from total ranking in the fourth quarter 2025 at 1343.

PRCT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Procept Biorobotics Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRCT Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 24.4 % 25.86 % 31.2 % 52.81 % 49.75 %
Y / Y Cost of Sales Growth 16 % 15.38 % 38.1 % 28.57 % 31.58 %
Inventory Turnover Ratio (TTM) 1.63 1.66 1.7 1.68 1.74
PRCT's Total Ranking # 615 # 1343 # 1039 # 992 # 490
Average inventory processing period 224 219 215 218 209
Seq. Inventory Growth 9.68 % 5.96 % -0.47 % 7.54 % 10.97 %
Seq. Cost of Sales Growth -3.33 % 3.45 % 7.41 % 8 % -3.85 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 245
Overall Market # 615

Inventory Turnover Ratio Statistics
High Average Low
1.99 1.72 1.14
(Mar 31 2022)   (Dec 31 2021)



PRCT Company Profile >> Back to PRCT Efficiency Comparisons >> Compare PRCT Inventory Turnover Ratio to its Competitors

Financial Statements
Procept Biorobotics's Inventories $ 78 Millions Visit PRCT's Balance sheet
Procept Biorobotics's Cost of Revenues TTM $ 115 Millions Visit PRCT's Income Statement
What are PRCT's Sales? Visit PRCT's Sales by Segment

Other Inventory Turnover Ratios
Procept Biorobotics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PRCT's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PRCT's Competitors
Inventory Turnover Ratio for PRCT's Suppliers
Inventory Turnover Ratio for PRCT's Customers

You may also want to know
PRCT's Sales Growth Rates PRCT's Pe Price to earnings ratio PRCT's Receivables Turnover Ratio PRCT's Stock Quote
PRCT's Net Income Growth Rates PRCT's Ps Price to Sales ratio PRCT's Sales per Employee PRCT's Asset Turnover Ratio
PRCT's Net Margin PRCT's Pb Price to Book ratio PRCT's Financial Strength Ratios PRCT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions
Myomo Inc   3.88 $ 14.000  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.84 $ 71.976  Millions$ 19  Millions
Escalon Medical Corp   3.79 $ 6.698  Millions$ 2  Millions
Evolus Inc   3.71 $ 103.000  Millions$ 28  Millions
Abbvie Inc   3.70 $ 18,420.000  Millions$ 4,975  Millions
Alpha Teknova Inc   3.69 $ 26.248  Millions$ 7  Millions
Biocryst Pharmaceuticals Inc   3.67 $ 19.884  Millions$ 5  Millions
Neuraxis Inc   3.61 $ 0.665  Millions$ 0  Millions
Mirum Pharmaceuticals Inc   3.50 $ 85.221  Millions$ 24  Millions
Tandem Diabetes Care Inc   3.42 $ 457.823  Millions$ 134  Millions
Exelixis Inc   3.41 $ 84.478  Millions$ 25  Millions
Baxter International Inc   3.37 $ 7,911.000  Millions$ 2,348  Millions
Gilead Sciences Inc   3.36 $ 6,139.000  Millions$ 1,825  Millions
Maravai Lifesciences Holdings Inc   3.33 $ 143.875  Millions$ 43  Millions
Intelligent Bio Solutions Inc   3.31 $ 2.064  Millions$ 1  Millions
Cadre Holdings inc   3.28 $ 372.000  Millions$ 113  Millions
Agilent Technologies inc   3.27 $ 3,418.000  Millions$ 1,047  Millions
Solventum Corporation  3.23 $ 3,363.000  Millions$ 1,042  Millions
Biofrontera Inc   3.22 $ 8.867  Millions$ 3  Millions
10x Genomics Inc   3.21 $ 193.000  Millions$ 60  Millions
Iovance Biotherapeutics inc   3.14 $ 165.941  Millions$ 53  Millions
Lftd Partners Inc   3.12 $ 28.258  Millions$ 9  Millions
Prestige Consumer Healthcare Inc   3.11 $ 493.000  Millions$ 159  Millions
Beyond Air Inc   3.07 $ 6.521  Millions$ 2  Millions
Bausch Health Companies Inc   3.07 $ 2,987.000  Millions$ 974  Millions
Indivior Pharmaceuticals Inc   3.03 $ 242.000  Millions$ 80  Millions

Date modified: 2026-08-30T15:03:09+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.